Alterations in Cellular Immune Markers Among Patients with Type 2 Diabetes Mellitus Compared to Healthy Controls
Nwaobi Anthony Chukwuka, Ugbomoiko Daniel Ohilebo, Emokpae Mathias Abiodun, Erameh Theophilus Ogie, Ezekiel Dauda Gambo, Erifeta Georgina Omonegho, Osaiyuwu Omoruyi Felix & Omogiade Christabel · International Journal of Biochemistry Research & Review · 2025
Introduction: In addition to hyperglycemia, type 2 diabetes mellitus (T2DM) is a chronic metabolic disease marked by immunological dysregulation and low-grade systemic inflammation. Changes in cellular immune markers, including CD4⁺ and CD8⁺ T lymphocytes, have been identified as...
Open access
Research Article
10.9734/ijbcrr/2025/v34i3999